| 000 | 01617 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250512194751.0 | ||
| 264 | 0 | _c19850214 | |
| 008 | 198502s 0 0 eng d | ||
| 022 | _a0004-4172 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEckert, H G | |
| 245 | 0 | 0 |
_aPharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man. _h[electronic resource] |
| 260 |
_bArzneimittel-Forschung _c1984 |
||
| 300 |
_a1435-47 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAngiotensin-Converting Enzyme Inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xmetabolism |
| 650 | 0 | 4 | _aAutoradiography |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aBridged Bicyclo Compounds _xmetabolism |
| 650 | 0 | 4 |
_aBridged-Ring Compounds _xmetabolism |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aEnterohepatic Circulation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaternal-Fetal Exchange |
| 650 | 0 | 4 |
_aMilk _xmetabolism |
| 650 | 0 | 4 |
_aPlacenta _xmetabolism |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 | _aRamipril |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aBadian, M J | |
| 700 | 1 | _aGantz, D | |
| 700 | 1 | _aKellner, H M | |
| 700 | 1 | _aVolz, M | |
| 773 | 0 |
_tArzneimittel-Forschung _gvol. 34 _gno. 10B _gp. 1435-47 |
|
| 999 |
_c6097373 _d6097373 |
||